FDA approves drug that extends survival in the most common type of lung cancer
The U.S. Food and Drug Administration today approved a new drug to treat non-small-cell lung cancer (NSCLC), offering patients new hope in fighting this difficult disease. Lung cancer is expected to lead to over 150,000 deaths ...
Dec 15, 2014
0
0